98
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Combined Pulmonary Tuberculosis with Pulmonary and Pleural Cryptococcosis in a Patient Receiving Ruxolitinib Therapy

ORCID Icon, , , &
Pages 3901-3905 | Published online: 21 Sep 2021

References

  • ZhangS, WangY, SanchezL, et al. Efficacy and safety of single-agent ruxolitinib therapy for myelofibrosis and polycythemia vera: a meta-analysis. Blood. 2015;126(23):1622. doi:10.1182/blood.V126.23.1622.1622
  • ZahrAA, SalamaME, CarreauN, et al. Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies. Haematologica. 2016;101(6):660–671. doi:10.3324/haematol.2015.14128327252511
  • LussanaF, CattaneoM, RambaldiA, et al. Ruxolitinib-associated infections: a systematic review and meta-analysis. Am J Hematol. 2018;93(3):339–347. doi:10.1002/ajh.2497629150886
  • SayabovornN, ChongtrakoolP, ChayakulkeereeM. Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review. BMC Infect Dis. 2021;21(1):27. doi:10.1186/s12879-020-05703-233413168
  • WyshamNG, SullivanDR, AlladaG. An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor. Chest. 2013;143(5):1478–1479. doi:10.1378/chest.12-160423648912
  • HiranoA, YamasakiM, SaitoN, et al. Pulmonary cryptococcosis in a ruxolitinib-treated patient with primary myelofibrosis. Respir Med Case Rep. 2017;22:87–90.28721333
  • PrakashK, RichmanD. A case report of disseminated histoplasmosis and concurrent cryptococcal meningitis in a patient treated with ruxolitinib. BMC Infect Dis. 2019;19(1):287. doi:10.1186/s12879-019-3922-630917797
  • QuJ, ZhangX, LuY, et al. Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China. Sci Rep. 2020;10:9387. doi:10.1038/s41598-020-66094-732523003
  • LiuK, DingH, XuB, et al. Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis. J Thorac Dis. 2016;8(10):2813–2821. doi:10.21037/jtd.2016.10.3627867557
  • HuangCT, TsaiYJ, FanJY, et al. Cryptococcosis and tuberculosis co-infection at a university hospital in Taiwan, 1993–2006. Infection. 2010;38(5):373–379. doi:10.1007/s15010-010-0045-920661622
  • FangW, ZhangL, LiuJ, et al. Tuberculosis/cryptococcosis co-infection in China between 1965 and 2016. Emerg Microbes Infect. 2017;6(8):e73. doi:10.1038/emi.2017.6128831193
  • KesslerAT, Al KharratT, KourtisAP. Cryptococcus neoformans as a cause of bronchiolitis obliterans organizing pneumonia. J Infect Chemother. 2010;16(3):206–209. doi:10.1007/s10156-010-0039-720169387
  • ChikumotoA, OishiK, HamadaK, et al. Cryptococcosis as a cause of organizing pneumonia. Respir Med Case Rep. 2019;27:100851.31110941
  • CordierJF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28(2):422–446. doi:10.1183/09031936.06.0001350516880372